3-38606571-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001099404.2(SCN5A):c.1140+98G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.803 in 1,409,404 control chromosomes in the GnomAD database, including 455,429 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.80   (  49377   hom.,  cov: 34) 
 Exomes 𝑓:  0.80   (  406052   hom.  ) 
Consequence
 SCN5A
NM_001099404.2 intron
NM_001099404.2 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.102  
Publications
16 publications found 
Genes affected
 SCN5A  (HGNC:10593):  (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022] 
SCN5A Gene-Disease associations (from GenCC):
- Brugada syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
 - Brugada syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - dilated cardiomyopathy 1EInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
 - familial long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - long QT syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
 - sick sinus syndrome 1Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
 - progressive familial heart block, type 1AInheritance: SD, AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
 - atrial standstillInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - familial sick sinus syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - paroxysmal familial ventricular fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - progressive familial heart blockInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
 - catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 - short QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BP6
Variant 3-38606571-C-T is Benign according to our data. Variant chr3-38606571-C-T is described in ClinVar as Benign. ClinVar VariationId is 1292202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.961  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.804  AC: 122321AN: 152094Hom.:  49327  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
122321
AN: 
152094
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.803  AC: 1008948AN: 1257192Hom.:  406052   AF XY:  0.804  AC XY: 498733AN XY: 620146 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1008948
AN: 
1257192
Hom.: 
 AF XY: 
AC XY: 
498733
AN XY: 
620146
show subpopulations 
African (AFR) 
 AF: 
AC: 
22361
AN: 
28706
American (AMR) 
 AF: 
AC: 
27574
AN: 
32846
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
18127
AN: 
22714
East Asian (EAS) 
 AF: 
AC: 
33836
AN: 
34806
South Asian (SAS) 
 AF: 
AC: 
62616
AN: 
72394
European-Finnish (FIN) 
 AF: 
AC: 
32160
AN: 
39796
Middle Eastern (MID) 
 AF: 
AC: 
3674
AN: 
4504
European-Non Finnish (NFE) 
 AF: 
AC: 
765744
AN: 
968376
Other (OTH) 
 AF: 
AC: 
42856
AN: 
53050
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 9403 
 18805 
 28208 
 37610 
 47013 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 18016 
 36032 
 54048 
 72064 
 90080 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.804  AC: 122429AN: 152212Hom.:  49377  Cov.: 34 AF XY:  0.809  AC XY: 60215AN XY: 74412 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
122429
AN: 
152212
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
60215
AN XY: 
74412
show subpopulations 
African (AFR) 
 AF: 
AC: 
32639
AN: 
41520
American (AMR) 
 AF: 
AC: 
12441
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2777
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
5095
AN: 
5178
South Asian (SAS) 
 AF: 
AC: 
4186
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
8610
AN: 
10600
Middle Eastern (MID) 
 AF: 
AC: 
243
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
54018
AN: 
68002
Other (OTH) 
 AF: 
AC: 
1721
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1259 
 2519 
 3778 
 5038 
 6297 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 878 
 1756 
 2634 
 3512 
 4390 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
3159
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.